Leucapher is a simple multi-therapeutic platform, designed to perform extracorporeal treatments directly on whole blood in patients suffering from Inflammatory Bowel Diseases (IBD), or others with inflammatory substrate:
- Leukocyte apheresis
- Hemoperfusion with predilution
The aim is to promote adsorption from the bloodstream of leukocytes, both neutrophils and lymphocytes or monocytes, as well as one part of platelets, thus modulating the inflammatory response.